691
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Methotrexate renal clearance by low-dose dopamine in severe nephrotoxicity

, , , &
Pages 362-363 | Received 23 Sep 2015, Accepted 22 Nov 2015, Published online: 04 Jan 2016

References

  • Mathisen MS1, Jabbour E, Kantarjian HM. Treatment of adult acute lymphoblastic leukemia (ALL) with a focus on emerging investigational and targeted therapies. Oncology. 2012;26(9):851–859.
  • Winograd B, Lippens RJ, Oosterbaan MJ, Dirks MJ, Vree TB, van der Kleijn E. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children. Eur J Clin Pharmacol. 1986;30(2):231–238.
  • Takeuchi A, Masuda S, Saito H, Doi T, Inui K. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate. Kidney Int. 2001;60(3):1058–1068.
  • Pereira CN, Machado FR, Guimarães HP, Senna AP, do Amaral JL. Hemodynamics and renal function during administration of low-dose dopamine in severely ill patients. Sao Paulo Med J. 2004;122(4):141–146.
  • Thomas DM, Coles GA, Williams JD. What does the renal reserve mean? Kidney Int. 1994;45(2):411–416.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.